Gastroenterology 136, 20032014
Benefits include improved fat metabolism, energy levels, and recovery
Symptoms can include: not being able to move your joints severe joint pain Pancreatitis
Lin MJ, Dai W, Scott MJ et al (2017) Metformin improves nonalcoholic fatty liver disease in obese mice via down-regulation of apolipoprotein A5 as part of the AMPK/LXR signaling pathway
As expected, treatment with sitagliptin led to a significant reduction in plasma DPP-4 activity at 12 months, but the levels of soluble DPP-4 and inflammatory markers remained unchanged [25]
While GLP-1 receptor agonists are generally well-tolerated, certain symptoms warrant prompt medical evaluation